Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement

PHASE4RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
IUDHealthy FemaleContraceptionIUD Insertion Complication
Interventions
DRUG

Ketorolac

Patients will get IV ketorolac during IUD placement under sedation

DRUG

Placebo

Patients will get IV placebo during IUD placement under sedation

Trial Locations (1)

72202

RECRUITING

Arkansas Childrens Hospital, Little Rock

All Listed Sponsors
lead

Arkansas Children's Hospital Research Institute

OTHER